Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.5, 2002-05, pp. : 709-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 875-889

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule HIV-1 Integrase Inhibitors: the 2001-2002 Update

Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. : 1789-1802

Bentham Science Publishers

Access to resources Recommend Favorite

Patented small molecule inhibitors of p53–MDM2 interaction

By Deng Jinxia Dayam Raveendra Neamati Nouri

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 165-188

Informa Healthcare

Access to resources Recommend Favorite

Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1818-1826

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Small Molecule HIV-1 Fusion Inhibitors: Linking Biology to Chemistry

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1827-1834

Bentham Science Publishers

Access to resources Recommend Favorite